Biofunctional Inorganic Layered Double Hydroxide Nanohybrid Enhances Immunotherapeutic Effect on Atopic Dermatitis Treatment
© 2023 Wiley‐VCH GmbH..
Atopic dermatitis (AD) is a widespread, recurrent, and chronic inflammatory skin condition that imposes a major burden on patients. Conventional treatments, such as corticosteroids, are associated with various side effects, underscoring the need for innovative therapeutic approaches. In this study, the possibility of using indole-3-acetic acid-loaded layered double hydroxides (IAA-LDHs) is evaluated as a novel treatment for AD. IAA is an auxin-class plant hormone with antioxidant and anti-inflammatory effects. Following the synthesis of IAA-LDH nanohybrids, their ability to induce M2-like macrophage polarization in macrophages obtained from mouse bone marrow is assessed. The antioxidant activity of IAA-LDH is quantified by assessing the decrease in intracellular reactive oxygen species levels. The anti-inflammatory and anti-atopic characteristics of IAA-LDH are evaluated in a mouse model of AD by examining the cutaneous tissues, immunological organs, and cells. The findings suggest that IAA-LDH has great therapeutic potential as a candidate for AD treatment based on its in vitro and in vivo modulation of AD immunology, enhancement of macrophage polarization, and antioxidant activity. This inorganic drug delivery technology represents a promising new avenue for the development of safe and effective AD treatments.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Small (Weinheim an der Bergstrasse, Germany) - 20(2024), 17 vom: 19. Apr., Seite e2304862 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Byun, Min Ji [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 25.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/smll.202304862 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM365418811 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM365418811 | ||
003 | DE-627 | ||
005 | 20240426233432.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/smll.202304862 |2 doi | |
028 | 5 | 2 | |a pubmed24n1388.xml |
035 | |a (DE-627)NLM365418811 | ||
035 | |a (NLM)38050931 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Byun, Min Ji |e verfasserin |4 aut | |
245 | 1 | 0 | |a Biofunctional Inorganic Layered Double Hydroxide Nanohybrid Enhances Immunotherapeutic Effect on Atopic Dermatitis Treatment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.04.2024 | ||
500 | |a Date Revised 25.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Wiley‐VCH GmbH. | ||
520 | |a Atopic dermatitis (AD) is a widespread, recurrent, and chronic inflammatory skin condition that imposes a major burden on patients. Conventional treatments, such as corticosteroids, are associated with various side effects, underscoring the need for innovative therapeutic approaches. In this study, the possibility of using indole-3-acetic acid-loaded layered double hydroxides (IAA-LDHs) is evaluated as a novel treatment for AD. IAA is an auxin-class plant hormone with antioxidant and anti-inflammatory effects. Following the synthesis of IAA-LDH nanohybrids, their ability to induce M2-like macrophage polarization in macrophages obtained from mouse bone marrow is assessed. The antioxidant activity of IAA-LDH is quantified by assessing the decrease in intracellular reactive oxygen species levels. The anti-inflammatory and anti-atopic characteristics of IAA-LDH are evaluated in a mouse model of AD by examining the cutaneous tissues, immunological organs, and cells. The findings suggest that IAA-LDH has great therapeutic potential as a candidate for AD treatment based on its in vitro and in vivo modulation of AD immunology, enhancement of macrophage polarization, and antioxidant activity. This inorganic drug delivery technology represents a promising new avenue for the development of safe and effective AD treatments | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a atopic dermatitis | |
650 | 4 | |a immunosuppression | |
650 | 4 | |a layered double hydroxides | |
650 | 4 | |a macrophage polarization | |
650 | 4 | |a nanohybrid | |
650 | 7 | |a Hydroxides |2 NLM | |
650 | 7 | |a Indoleacetic Acids |2 NLM | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a indoleacetic acid |2 NLM | |
650 | 7 | |a 6U1S09C61L |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
700 | 1 | |a Seo, Hee Seung |e verfasserin |4 aut | |
700 | 1 | |a Lee, Joonghak |e verfasserin |4 aut | |
700 | 1 | |a Ban, Kitae |e verfasserin |4 aut | |
700 | 1 | |a Oh, Serim |e verfasserin |4 aut | |
700 | 1 | |a Lee, Yun Young |e verfasserin |4 aut | |
700 | 1 | |a Lim, Jaesung |e verfasserin |4 aut | |
700 | 1 | |a Lee, Na Kyeong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Chi-Pin James |e verfasserin |4 aut | |
700 | 1 | |a Kim, Minjeong |e verfasserin |4 aut | |
700 | 1 | |a Han, Jun-Hyeok |e verfasserin |4 aut | |
700 | 1 | |a Park, Juwon |e verfasserin |4 aut | |
700 | 1 | |a Paik, Taejong |e verfasserin |4 aut | |
700 | 1 | |a Park, Hee Ho |e verfasserin |4 aut | |
700 | 1 | |a Park, Tae-Eun |e verfasserin |4 aut | |
700 | 1 | |a Park, Wooram |e verfasserin |4 aut | |
700 | 1 | |a Kim, Se-Na |e verfasserin |4 aut | |
700 | 1 | |a Park, Dae-Hwan |e verfasserin |4 aut | |
700 | 1 | |a Park, Chun Gwon |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Small (Weinheim an der Bergstrasse, Germany) |d 2005 |g 20(2024), 17 vom: 19. Apr., Seite e2304862 |w (DE-627)NLM167400452 |x 1613-6829 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2024 |g number:17 |g day:19 |g month:04 |g pages:e2304862 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/smll.202304862 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2024 |e 17 |b 19 |c 04 |h e2304862 |